The proliferation and invasiveness of glioma cells were reversed by HDAC7 silencing or HDAC7 inhibition, as confirmed by MTT assay and Transwell assay, respectively (Fig. 6a-d, Additional file 2: Figure S5). The gene discussed is HDAC7; the disease is central nervous system cancer.